Bosutris 100 Tablet
By Bosutris
Rx
120 Tablet in a Bottle

Composition
Bosutinib(100mg)

Manufacturer - Mylan Pharmaceuticals Pvt Ltd
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103

Expires on or after
July, 2025

liver
For individuals with liver disease, it is important to exercise caution when using Bosutris 100 Tablet. This medication may require a dose adjustment in such cases, so it is crucial to consult your doctor before starting treatment. Bosutris 100 mg Tablet has been associated with hepatotoxicity, which can be harmful to the liver. Therefore, it is essential to inform your doctor if you have any existing liver issues or a history of liver disease. Your doctor may need to adjust the dose according to your specific condition to ensure your safety.

kidney
Caution should be taken when using Bosutris 100 Tablet in patients with kidney disease. Consult your doctor for possible dose adjustments. Inform your doctor if you have a history of kidney issues to determine the most suitable treatment option.

alcohol
Avoid alcohol while taking Bosutris 100 Tablet to prevent harmful effects. Consult your doctor for guidance.

driving
Caution should be taken while driving when using Bosutris 100 Tablet. It may cause dizziness and drowsiness, potentially affecting your ability to concentrate and react. Refrain from driving until you are fully alert.

pregnancy
Bosutris 100 Tablet is not safe to use during pregnancy, as it may harm the developing baby. Only in critical situations, a doctor might suggest it if the benefits are greater than the risks. Kindly consult your doctor before using it.

breastfeeding
Bosutris 100 Tablet is not recommended during breastfeeding, as it may transfer into breastmilk and potentially harm the baby. It is advisable to consult a doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | 4-aminoquinolines |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹11000
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025